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The data in this article is related to the research article entitled,
“Targeting of Multiple Oncogenic Signaling Pathways by Hsp90
Inhibitor Alone or in Combination with Berberine for Treatment of
Colorectal Cancer” [1]. Overexpression of survivin induces resistance to
various anticancer therapies such as chemotherapy and radiation
therapy in colorectal cancer (CRC) cells. To determine signiﬁcant
correlations of biological functions/pathways with survivin, 4567
signiﬁcant genes were analyzed from the GEO DataSet (GSE21815) of
CRC and these were overlaid onto a global molecular network
developed from information contained in the Ingenuity Pathway
Analysis (IPA) database. The data here present the most signiﬁcantcess article under the CC BY license
/j.bbamcr.2015.05.012
7627; fax: þ886 2 66387537.
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cellular functions and signiﬁcant categories in physiological develop-
ment/system functions which were associated with CRC. The top 10
canonical signaling pathways associated with CRC were categorize in
order based on the level of statistical signiﬁcance.
& 2015 Elsevier Inc. This is an open access article under the CC BY
license (http://creativecommons.org/licenses/by/4.0/).Speciﬁcations tableSubject area Medicine, biology
More speciﬁc
subject areaMolecular biology, Cancer biologyType of data Table
How data was
acquiredMicroarray data were obtained from the Gene Expression Omnibus (GEO) repository at the NCBI
were analyzed using the Ingenuity pathway analysis (IPA) databaseData format Analyzed
Experimental factors None
Experimental
featuresGene expression data of 132 samples of laser microdissected CRC tumors and nine normal colon
controls were retrieved from the GEO DataSet under the accession number GSE21815 and imported
into the IPA Tool to determine signiﬁcant correlations of biological functions/pathways with survivinData source location Taipei, Taiwan
Data accessibility The data are supplied with this articleValue of the data This data provides a comprehensive analysis of CRC patients gene expression proﬁling and
identiﬁes cell death and survival were the top signiﬁcant molecular and cellular functional
categories, EIF2 signaling, the protein ubiquitination pathway, and the eIF4/p70S6K signaling
pathway were the most signiﬁcant pathways in the upregulated CRC gene set. The data are useful for understanding the signaling pathway in the upregulated CRC gene set to be
associated with survivin expression. This data may provide insight for determination the drug for combinational treatment of CRC.1. Data, experimental design, materials and methods
1.1. Acquisition and processing of public microarray data
The public microarray data will be used here were obtained from the NNCBI GEO website
(GSE21815). Simple Omminus Format in Text (SOFT) ﬁles corresponding to the complete contents of
GEO platform GPL6480 will be downloaded via FTP. The sequence information used to design this
product was derived from a broad survey of well known sources such as RefSeq, Ensembl and
Unigene. The resulting view of the human genome covers 41 K unique genes and transcripts which
have been veriﬁed and optimized by alignment to the human genome assembly and by Agilent's
Empirical Validation process. Microarray expression data for the GEO data set will be retrieved for 132
stages I to IV CRC and 9 normal control from the NCBI GEO (GSE21815).
Table 1
Biological functions associated with CRC.
Network Top functions p value Focus genes
Diseases and disorders
1 Cancer 2.09E13 to 2.16E03 1795
2 Infectious diseases 1.50E22 to 1.50E05 754
3 Renal and urological diseases 8.10E18 to 8.01E05 228
4 Organismal injury and abnormalities 1.62E18 to 1.62E18 164
5 Dermatological diseases and conditions 4.43E18 to 4.43E18 163
Molecular and cellular functions
1 Cell death and survival 7.64E18 to 2.46E03 1427
2 Gene expression 2.37E20 to 2.51E04 1013
3 Cell cycle 2.82E22 to 2.57E03 801
4 DNA replication, recombination, and repair 8.36E23 to 2.46E03 648
5 RNA post-transcriptional modiﬁcations 1.22E37 to 9.81E04 214
Physiological system development and function
1 Connective tissue development and functions 2.64E10 to 2.46E03 333
2 Embryonic development 3.37E12 to 1.73E03 323
3 Tissue morphology 8.40E07 to 2.39E03 255
4 Organismal development 2.27E07 to 1.73E03 220
5 Tissue development 6.03E08 to 2.07E03 119
Table 2
Top 10 signiﬁcantly changed canonical signaling pathways between CRC patients and normal
controls.
Canonical pathway  log (p value)
EIF2 signaling 3.03E01
Protein ubiquitination pathway 2.38E01
Regulation of eIF4 and p70S6K signaling 1.64E01
Hereditary breast cancer signaling 1.19E01
Role of BRCA1 in DNA damage response 1.16E01
Mitotic roles of polo-like kinase 1.13E01
tRNA charging 1E01
mTOR signaling 9.18E00
Cell cycle control of chromosomal replication 9.02E00
Role of CHK proteins in cell cycle checkpoint control 8.09E00
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Gene expression data of 132 samples of laser microdissected CRC tumors and 9 normal
colon controls of patients with no colorectal neoplasm were retrieved from the GEO DataSet under
the accession number GSE21815 and imported into the IPA Tool (Ingenuity H Systems, Redwood City,
CA, USA; http://www.ingenuity.com). A fold difference of 2.0-fold (up-regulated) or 0.5-fold
(down-regulated) was considered signiﬁcant and was applied prior to pathway analyses. Based on
the Ingenuity Knowledge Base different networks, biological processes and/or diseases were then
algorithmically generated based on connectivity of genes within the datasets. Focus molecules were
identiﬁed by IPA on the basis of highest connectivity. Comparisons will be performed between CRC
group or control. The genes showing signiﬁcant differences in expression levels between groups will
be submitted to IPA for human diseases and disorders, molecular and cellular functions categories and
pathway analysis.
The most signiﬁcant disease and disordered biological functions associated with CRC-correlated
genes were related to cancer (Table 1, upper panel). Cell death and survival were the top signiﬁcant
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and function were the most signiﬁcant categories in physiological development and system function
(Table 1, bottom panel). To gain further insights into the pathogenesis of CRC, we analyzed CRC-
correlated genes to elucidate dominant canonical pathways. The top 10 canonical signaling pathways
were categorized in order based on the level of statistical signiﬁcance (Table 2). Results of the pathway
analysis showed that EIF2 signaling, the protein ubiquitination pathway, and the eIF4/p70S6K
signaling pathway were the most signiﬁcant pathways in the upregulated CRC gene set. Hsp90
inhibitors, such as geldanamycin, 17-AAG and NVP-AUY922 have been demonstrated to induce the
overexpression of survivin to enhance cell survival and chemotherapy resistance in HT-29 cells [2].
More, mTOR/p70S6K signaling has been identiﬁed to be the upstream regulator of survivin [3]. Thus,
targeting the mTOR/p70S6K/survivin axis is thus an attractive strategy in developing therapeutic
agents against cancer cells with chemoresistance.
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